Skip to main content

Table 1 Mean and Median Counts of Indicators of Overuse Across Regions, 2010 months 1–6 (N = 422 regions)

From: Systemic overuse of health care in a commercially insured US population, 2010–2015

Overuse Indicator Per 1000
Mean Median Interquartile Range
Stress echocardiography in symptomatic or ischemic equivalent acute chest paina 52.4 36.6 0.0 72.8
Laminectomy or spinal fusion 0.6 0.6 0.4 0.8
Hysterectomy for benign disease 3.5 3.3 2.5 4.3
Fiberoptic laryngoscopy for sinusitis diagnosisa 2.4 1.6 0.7 3.0
Nasal endoscopy for sinusitis diagnosisa 21.3 16.4 9.5 28.5
Routine monitoring of digoxin in patients with congestive heart failure 18.7 16.6 9.6 23.5
EEG monitoring in individuals presenting with syncopea 59.6 55.3 39.2 75.4
Serological tests for Helicobacter pylori 4.2 4.1 2.8 5.4
MRI in adults with mild traumatic brain injurya 22.9 20.8 7.5 31.3
PET, CT, and radionuclide bone scan in individuals with low-risk prostate cancer 112 105 80.3 135
Traction for low back pain 222 216 169 271
Screening for asymptomatic carotid artery stenosis in the general adult population 1.3 1.1 0.8 1.6
Preoperative chest radiography in the absence of a clinical suspiciona 135 118 89.6 165
Tumor marker studies in asymptomatic women with previously treated breast cancer 289 272 165 386
Diagnostic tests, such as immunoglobulin testing, in the evaluation of allergya 12.2 10.5 5.9 16.7
Sinus CT for uncomplicated acute rhinosinusitisa 1.1 0.9 9.0 1.4
MRI lumbar spine for low back paina 491 493 454 530
Thorax CT use with and without contrasta 70.2 47.4 22.9 94.0
Abdomen CT use with and without contrasta 182 136 90.6 259
  1. CT Indicates computed tomography, EEG Electroencephalography, MRI Magnetic resonance imaging, PET Positron emission tomography
  2. aCount is per 1000 eligible episodes rather than per 1000 beneficiaries
\